Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition
Both in vitro cytotoxicity and in vivo safety assays demonstrated a favorable biosafety profile for the liposomal drug depot
This study used cutoffs of 15, 20, and 10 U/L to define elevated levels of DAO, LPS, and D-lactate, respectively, and reported that a greater percentage of hypertensive patients met the criteria for elevated LPS and DAO, but not D-lactate, compared to normotensive patients
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Before proceeding, confirm that donor screening protocols meet international standards